Marshall Wace North America’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $5.17M | Sell |
338,301
-72,958
| -18% | -$1.11M | 0.02% | 496 |
|
|
2021
Q2 | $7.66M | Buy |
+411,259
| New | +$7.66M | 0.03% | 426 |
|
|
2020
Q4 | – | Sell |
-24,531
| Closed | -$272K | – | 1619 |
|
|
2020
Q3 | $272K | Sell |
24,531
-6,475
| -21% | -$71.8K | ﹤0.01% | 1085 |
|
|
2020
Q2 | $389K | Buy |
31,006
+6,194
| +25% | +$77.7K | ﹤0.01% | 968 |
|
|
2020
Q1 | $282K | Buy |
24,812
+9,873
| +66% | +$112K | ﹤0.01% | 858 |
|
|
2019
Q4 | $196K | Buy |
+14,939
| New | +$196K | ﹤0.01% | 970 |
|